PureTech Health Aktie
1,97EUR | 0,08EUR | 4,23% |
WKN DE: A14VK6 / ISIN: GB00BY2Z0H74
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 87,97 |
Invesco UK Invt. Ser. - Equity High Income Fund (UK) | 11,77 |
Invesco UK 2 Investment Series - Equity Income Fund (UK) | 5,36 |
M&G Investment Management Ltd. | 3,84 |
Edinburgh Worldwide Investment Trust Plc | 2,41 |
Baillie Gifford Overseas Growth Fund - Global Discovery Fund | 2,17 |
Ruffer LLP | 1,72 |
JOHCM Umbrella Fund Plc - UK Growth Fund | 1,65 |
Raju S. Kucherlapati, PhD | 1,03 |
Joichi Ito, PhD | 0,58 |
AWM Investment Co., Inc. | 0,54 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 300 | 66 | 0 | 0 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,03 | 0,14 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. GBP) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 127 | 303 | 370 | 321 | 272 |
Summe Anlagevermögen | 583 | 421 | 328 | 263 | 272 |
Summe Aktiva | 710 | 724 | 698 | 584 | 544 |
Bilanz (in Mio. GBP) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 106 | 143 | 167 | 62 | 20 |
Summe Fremdkapital | 219 | 246 | 267 | 129 | 185 |
Summe Eigenkapital | 491 | 478 | 431 | 455 | 359 |
Summe Passiva | 710 | 724 | 698 | 584 | 544 |
Adresse
6 Tide Street, 02210 Boston | |
Telefon | +1 (617) 482-2333 |
Fax | +1 (617) 482-3337 |
Internet | https://puretechhealth.com |
Management
Aleksandra Filipovic
Head-Oncology |
Allison Mead Talbot
VP-Communications & Investor Relations |
Anita Terpstra
Senior Vice President-Head-Intellectual Property |
Bharatt M. Chowrira
Chief Executive Officer & Director |
Charles Sherwood
General Counsel |
Eric Elenko
President |
John L. LaMattina
Independent Non-Executive Director |
Kiran Mazumdar-Shaw
Independent Non-Executive Director |
Michele A. M. Holcomb
Independent Non-Executive Director |
Raju S. Kucherlapati
Chairman |
Robert S. Langer
Non-Executive Director |
Robert William Henry Lyne
Chief Portfolio Officer |
Sharon Barber-Lui
Independent Non-Executive Director |